Lactylation: a metabolic–epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting - Summary - MDSpire

Lactylation: a metabolic–epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting

  • By

  • Wenbo Lv

  • Linxi Xie

  • Jintao Tao

  • Qingqi Xu

  • Wenfeng Hu

  • Hao Xie

  • Pin Lu

  • Ying Xu

  • Liang Huang

  • June 26, 2026

  • 0 min

Share

Objective:

To summarize the molecular mechanisms through which lactylation contributes to the initiation and progression of atherosclerosis (AS).

Approach:
  • Lactylation Mechanism Overview: Lactylation involves the addition of lactate-derived lactyl groups to lysine residues on proteins, affecting their function and stability.
  • Role in Atherosclerosis: The review discusses lactylation's involvement in key pathological processes of AS, including inflammation, endothelial–mesenchymal transition, angiogenesis, and vascular smooth muscle cell senescence.
Key Findings:
  • Lactylation regulates several pathological processes associated with atherosclerosis.
  • Lactate is converted into lactyl-CoA, which is transferred to proteins by lactyltransferases.
  • Histone acetyltransferase p300 may act as a lactyltransferase, influencing histone lactylation.
  • Delactylases, such as certain histone deacetylases, may remove lactyl groups, regulating lactylation.
Interpretation:

Lactylation plays a significant role in the pathophysiology of atherosclerosis, linking metabolic dysregulation and epigenetic changes.

Limitations:
  • The review lacks a systematic discussion of lactylation's specific roles in atherosclerosis compared to other modifications.
  • Further research is needed to fully elucidate the context-dependent effects of lactylation.
Conclusion:

Understanding lactylation's role in atherosclerosis may lead to novel therapeutic strategies targeting this modification.

Original Source(s)

Related Content